A detailed history of Avidity Partners Management LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Avidity Partners Management LP holds 200,000 shares of IMCR stock, worth $6.67 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
200,000
Previous 286,400 30.17%
Holding current value
$6.67 Million
Previous $18.6 Million 63.59%
% of portfolio
0.33%
Previous 0.72%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$33.78 - $63.75 $2.92 Million - $5.51 Million
-86,400 Reduced 30.17%
200,000 $6.78 Million
Q1 2024

May 15, 2024

SELL
$60.14 - $75.36 $829,932 - $1.04 Million
-13,800 Reduced 4.6%
286,400 $18.6 Million
Q4 2023

Feb 14, 2024

SELL
$42.85 - $69.5 $2.06 Million - $3.34 Million
-48,000 Reduced 13.79%
300,200 $20.5 Million
Q3 2023

Nov 14, 2023

SELL
$49.5 - $66.6 $11.2 Million - $15.1 Million
-226,800 Reduced 39.44%
348,200 $18.1 Million
Q2 2023

Aug 14, 2023

SELL
$48.54 - $61.64 $9.46 Million - $12 Million
-194,800 Reduced 25.31%
575,000 $34.5 Million
Q1 2023

May 15, 2023

SELL
$46.12 - $65.71 $17.7 Million - $25.2 Million
-384,200 Reduced 33.29%
769,800 $38.1 Million
Q4 2022

Feb 14, 2023

SELL
$45.51 - $65.08 $42.1 Million - $60.2 Million
-925,100 Reduced 44.5%
1,154,000 $65.9 Million
Q3 2022

Nov 14, 2022

BUY
$37.34 - $57.44 $27.2 Million - $41.9 Million
729,100 Added 54.01%
2,079,100 $97.6 Million
Q2 2022

Aug 15, 2022

SELL
$25.46 - $37.72 $351,348 - $520,536
-13,800 Reduced 1.01%
1,350,000 $50.4 Million
Q1 2022

May 16, 2022

BUY
$18.94 - $34.29 $2.53 Million - $4.59 Million
133,800 Added 10.88%
1,363,800 $40.8 Million
Q4 2021

Feb 14, 2022

BUY
$27.58 - $40.0 $3.71 Million - $5.38 Million
134,400 Added 12.27%
1,230,000 $42.1 Million
Q3 2021

Nov 15, 2021

BUY
$27.98 - $40.0 $13.8 Million - $19.8 Million
494,600 Added 82.3%
1,095,600 $40.6 Million
Q2 2021

Aug 16, 2021

BUY
$32.22 - $41.5 $1.64 Million - $2.12 Million
51,000 Added 9.27%
601,000 $23.5 Million
Q1 2021

May 17, 2021

BUY
$36.3 - $56.34 $20 Million - $31 Million
550,000 New
550,000 $23.4 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.46B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.